FUJIFILM Diosynth Biotechnologies

Recently, our Hillerød, Denmark site had the opportunity to host Morten Bødskov, Danish Minister of Industry, Business, and Financial Affairs. Read President & CEO Lars Petersen’s thoughts on this visit:

We believe that fostering a vibrant, connected workplace is key to driving innovation and collaboration. Our RTP-North Carolina site recently embraced the season with Spirit Week, and the energy from our teams was nothing short of incredible! From Team Tuesday, where groups came together with creative themes, to Sports Day, Haunt It Flaunt It (Halloween costumes), Throwback Thursday, and Genki Day—it was a week full of fun, laughter, and team spirit. A huge thank you to everyone who participated, bringing your best energy and creativity! It was fantastic to see our employees embodying Genki and our company values through it all. #Teamwork #CompanyCulture #SpiritWeek #EmployeeEngagement

We are proud to share that our colleagues from FUJIFILM Diosynth Biotechnologies in College Station, Texas sponsored and volunteered at the 10th Annual Bryan College Station Oktoberfest Half Marathon & 10K on October 13. For the past five years, FUJIFILM Diosynth Biotechnologies has proudly supported this event, which benefits the Mercy Project, a local non-profit dedicated to eradicating child slavery in Ghana through economic development and sustainability. Our team was honored to volunteer at the finish line, passing out medals and water to the incredible runners who participated in this meaningful cause. Thank you to everyone who helped make this event a success! #CommunitySupport #MercyProject #Oktoberfest #Marathon #Advocacy

🎓 We are proud to celebrate the first cohort of PhD graduates from our Centre of Excellence in Bioprocessing! Read more about their journey today: https://lnkd.in/eN4EZTra This milestone marks a significant step in advancing bioprocessing innovation and training the next generation of industry leaders. Check out the link above to learn more about their journey and how our Centre of Excellence is shaping the future of biopharmaceutical development by driving cutting-edge research and fostering talent. #Biotechnology #PhDGraduates #CentreOfExcellence #Bioprocessing #Innovation

Breaking new ground in VGT development 🧬 High dose delivery has long been an industry bottleneck, but Fujifilm Bio Science and Engineering Laboratories is leading the charge with a revolutionary continuous electroporation device. Historically hindered by low throughput and poor cell viability, this new technology promises to eliminate the need for chemically mediated transfection. Debuting in our Texas demo labs, this device projects to improve viral vector productivity, streamline manufacturing processes, and make VGTs more economically viable. Read more here: https://lnkd.in/eFyTpTzW #VGT #Development #Transfection #Technology #ViralVector #Manufacturing #Engineering

Successful delivery of a bispecific antibody therapeutic to patients necessitates a manufacturing strategy that can accommodate the unique size, structure, and complexity of these molecules to ensure quality. We can perform manufacturability assessments to help clients choose the most suitable candidate for cell line development (CLD) and de-risk the development process. Read our full article by Dr. Fay Saunders, Director of Mammalian Cell Culture, Process Development to find out more! https://lnkd.in/eZYr8wiz #ProcessDevelopment #Biopharma #DrugDevelopment #Pharmaceuticals #BioManufacturing

Join Leon Pybus as he chairs a session and presents at Integrated Continuous Biomanufacturing VI, taking place from October 20-24, 2024 in Leesburg, Virginia, USA. Leon’s presentation, titled “Developing a Control Strategy for Integrated Semi-Continuous Bioprocessing,” will explore the potential of integrated continuous biomanufacturing (ICB) for clinical and commercial cGMP production. He’ll discuss how strategic approaches can streamline processes, bridging the gap between batch and continuous operations to enhance efficiency. Don’t miss the opportunity to hear Leon and other industry experts discuss the latest advancements in automation, process control, and PAT that are driving ICB adoption. #ICB2024 #Biomanufacturing #Automation #ProcessControl #PAT #ContinuousManufacturing

We are pleased to share that Charlie Heise, Associate Director of Bioprocessing Strategy & Development, is joining an insightful roundtable discussion at The Festival of Biologics. 🗓 Today, October 16, 11:40 AM Roundtable Speaker Expertise: Flexible Facility Design for Multi-Modal Drug Manufacturing. Charlie will be exploring the critical role of flexible facility design in addressing the complexities of multi-modal drug production. Join this session for a dive into innovative strategies that are shaping the future of biomanufacturing. We look forward to seeing you there! #FestivalOfBiologics #Biomanufacturing #FacilityDesign #Innovation #Biotechnology

Day 1 of The Festival of Biologics in Basel is underway, and FUJIFILM Diosynth Biotechnologies is excited to be part of it! Join us at Booth 1131 to explore our innovative biologics capabilities, and don’t miss our presentation at 11:55 AM with Charles Heise: “From Apollo™X cell line to 20K L Bioreactor: partnering manufacturing strategies and facility design for patient-centric medicine delivery.” Whether you’re here for insights, partnerships, or just to connect with fellow industry leaders, we’re ready to chat. Let’s make the most of this exciting first day in Basel! #FestivalOfBiologics #Basel #Biotechnology #Biologics #Innovation #PatientCentric #LifeSciences #PharmaInnovation #BiotechConference #Networking

Our history as an innovator company gives us a unique ability to assist our partners as they advance their own cell and gene therapy programs today. Having once been in their position, we understand firsthand the requirements and challenges associated with developing innovative therapies. This inside-out perspective allows us to fully support and guide our clients at every stage of the product lifecycle. In this short article, we will share insights from our leadership team about the challenges we encountered as an innovator company working with external organizations. We will also discuss how these experiences have shaped our current practices and our vision for the evolving relationship with CDMOs in the future. https://lnkd.in/eE7j-qR7 #CellTherapy #GeneTherapy #CDMO #LifeSciences #Biopharma #HealthcareInnovation